Encoding 发表于 2025-3-26 23:39:27

Issues in Community-Acquired Pneumonia,have been developed over the past decade to assist emergency department physicians to recognize, admit, and implement rapid antimicrobial therapy in severely ill patients. The evidence for the beneficial effects of these tools will be reviewed in this chapter. Issues in the management of severe comm

背心 发表于 2025-3-27 03:28:16

http://reply.papertrans.cn/25/2415/241426/241426_32.png

BUDGE 发表于 2025-3-27 09:15:41

Major Advances in Hepatitis C Treatment but Not Hepatitis B,t curative and significant therapeutic advances have not been realized. This chapter reviews the biology and pathogenesis of the two viruses and discusses current available therapies and future trends.

吞噬 发表于 2025-3-27 13:25:17

Infectious Complications of Biological Agents,t were also complicated by increased infections, seen especially with corticosteroids, methotrexate, and cyclophosphamide. This chapter reviews the mechanisms of these novel therapeutic agents and their infectious complications in comparison to standard DMARDs, and also evaluates the risk of infecti

使满足 发表于 2025-3-27 13:58:36

http://reply.papertrans.cn/25/2415/241426/241426_35.png

翻动 发表于 2025-3-27 18:46:55

http://reply.papertrans.cn/25/2415/241426/241426_36.png

minimal 发表于 2025-3-27 22:57:32

Issues and Concerns in the Management of Systemic Candidiasis,ultidrug resistant yeast, ., in the last 10 years that has been spreading globally with inter- and intra-hospital transmission. This chapter discusses the evidence to support guidelines recommendations for an echinocandin as initial therapy for invasive candidiasis over fluconazole.

正式通知 发表于 2025-3-28 04:44:44

http://reply.papertrans.cn/25/2415/241426/241426_38.png

heirloom 发表于 2025-3-28 09:25:26

http://reply.papertrans.cn/25/2415/241426/241426_39.png

商议 发表于 2025-3-28 10:33:20

http://reply.papertrans.cn/25/2415/241426/241426_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Current Trends and Concerns in Infectious Diseases; I. W. Fong Book 2020 Springer Nature Switzerland AG 2020 Immune Reconstitution Syndrom